EXAVIR THERAPEUTICS INC.

EXAVIR THERAPEUTICS INC. is a biotech company in Omaha, United States, founded in 2023. It has raised $8.0M across 3 rounds, most recently a $4.0M Seed in June 2024.

Exavir Therapeutics

Headquarters
Omaha, Nebraska
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$8.0M
Last Round
$4.0M SeedJun 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Exavir Therapeutics is developing a combination treatment regimen for people with HIV and for those with HIV and HBV co-infection. Its development approach pairs the investigational agent XV-207 with XV-122, bringing the two programs together as partner agents intended to provide a complete treatment regimen.

Summary

It lists 1–10 employees. It has raised $8.0M in total across 3 rounds, most recently a $4.0M Seed round in Jun 2024. Investors include AlleyCorp, National Institute of Allergy and Infectious Diseases and Gilead Sciences.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundJun 2024
$4.0M

Sign up to see all 3 events

Funding: Grant through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EXAVIR THERAPEUTICS INC. on Indexed.vc
<a href="https://indexed.vc/companies/exavir-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/exavir-therapeutics-inc" alt="EXAVIR THERAPEUTICS INC. on Indexed.vc" width="260" height="76" /></a>